Advocacy & Practice Updates — Advocacy & Practice
ASRS, Ophthalmic Community Reccomend CMS Exempt Ophthalmology From MIPS Diabetes Cost Measure
The ASRS, the American Academy of Ophthalmology (AAO), and the American Society of Cataract and Refractive Surgery (ASCRS) sent a letter to CMS advising them that ophthalmologists are being inappropriately attributed the diabetes episode-based cost measure on their 2022 MIPS preview reports. ASRS participated in the development of the measure, which is intended to evaluate the clinician providing care for the patient’s underlying diabetes, rather than specialists managing co-morbidities, including retinal disease. We point out that there are inconsistencies in CMS’ guidance which may have contributed to this situation and recommend that the agency rectify the situation simply by exempting all ophthalmologists from the measure.
To access your 2022 MIPS preview report, login to your MIPS portal. If you have received a Cost score with the diabetes episode measure, please contact Allison Madson.
(Published 6.28.23)